KMBJN, you should email Leo that comment by some bio president, I'm sure he would get a laugh from it:
He talks to biotech and pharma management quite a bit, and sent me a very brief note the other day that some antibiotic company's president told him "there is significant renal toxicity." I was very surprised and pointed him to links showing no such thing in 250+ patients in the two Phase II studies. So either the other antibiotic company's president is wrong out of ignorance (more likely), willfully spreading misinformation (possible?), or somehow correct (highly doubtful).
Market Data 
Markets 
AI
